ProfileGDS4718 / 234423_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 50% 46% 42% 51% 37% 39% 43% 44% 40% 40% 48% 22% 35% 35% 43% 44% 40% 35% 52% 40% 43% 38% 45% 46% 30% 48% 44% 51% 36% 40% 40% 50% 40% 39% 35% 39% 44% 44% 42% 42% 44% 44% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4939550
GSM549102patient 115, normal, homogenized [OPG study]5.561550
GSM549104patient 119, normal, homogenized [OPG study]5.3115146
GSM549108patient 138, normal, homogenized [OPG study]5.1365542
GSM549119patient 077, normal, homogenized [OPG study]5.5545351
GSM549133patient 032, cancer, homogenized [OPG study]4.7863237
GSM549139patient 042, cancer, homogenized [OPG study]4.9287739
GSM549099patient 107, normal, homogenized [OPG study]5.1589843
GSM549109patient 139, normal, homogenized [OPG study]5.2169844
GSM549110patient 046, normal, homogenized [OPG study]4.9790640
GSM549114patient 063, normal, homogenized [OPG study]4.9699440
GSM549122patient 082, normal, homogenized [OPG study]5.4157848
GSM549134patient 033, cancer, homogenized [OPG study]4.21122
GSM549136patient 036, cancer, homogenized [OPG study]4.6977635
GSM549140patient 044, cancer, homogenized [OPG study]4.7292335
GSM549111patient 047, normal, homogenized [OPG study]5.138843
GSM549113patient 057, normal, homogenized [OPG study]5.1459344
GSM549132patient 031, cancer, homogenized [OPG study]4.9809540
GSM549137patient 038, cancer, homogenized [OPG study]4.749535
GSM549142patient 047, cancer, homogenized [OPG study]5.7390452
GSM549100patient 110, normal, homogenized [OPG study]5.021340
GSM549107patient 135, normal, homogenized [OPG study]5.0880543
GSM549115patient 068, normal, homogenized [OPG study]4.8287238
GSM549116patient 072, normal, homogenized [OPG study]5.2198545
GSM549120patient 078, normal, homogenized [OPG study]5.2896846
GSM549131patient 030, cancer, homogenized [OPG study]4.4798830
GSM549118patient 074, normal, homogenized [OPG study]5.3947248
GSM549129patient 027, cancer, homogenized [OPG study]5.2105144
GSM549123patient 088, normal, homogenized [OPG study]5.562251
GSM549124patient 006, cancer, homogenized [OPG study]4.8521636
GSM549126patient 015, cancer, homogenized [OPG study]4.9825440
GSM549128patient 025, cancer, homogenized [OPG study]4.9569240
GSM549103patient 117, normal, homogenized [OPG study]5.5388250
GSM549117patient 073, normal, homogenized [OPG study]4.9365140
GSM549138patient 041, cancer, homogenized [OPG study]4.9186739
GSM549141patient 045, cancer, homogenized [OPG study]4.6908735
GSM549130patient 028, cancer, homogenized [OPG study]4.9440739
GSM549101patient 111, normal, homogenized [OPG study]5.2330244
GSM549105patient 128, normal, homogenized [OPG study]5.1859944
GSM549106patient 134, normal, homogenized [OPG study]5.0266742
GSM549112patient 048, normal, homogenized [OPG study]5.0799942
GSM549125patient 011, cancer, homogenized [OPG study]5.2156844
GSM549127patient 024, cancer, homogenized [OPG study]5.2003344
GSM549135patient 035, cancer, homogenized [OPG study]4.8166737